Dr. Piris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Crawford St
Ste 100
Needham, MA 02494Phone+1 617-969-4100
Education & Training
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Dermatopathology, 2006 - 2007
- Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1998 - 2000
- Universidad Nacional de Asuncion Faculty of MedicineClass of 1993
Certifications & Licensure
- RI State Medical License 2020 - 2026
- MA State Medical License 2006 - 2025
- FL State Medical License 2017 - 2022
- OH State Medical License 2017 - 2022
- VA State Medical License 2018 - 2020
- NH State Medical License 2017 - 2019
- NJ State Medical License 2017 - 2019
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Dermatopathology
- Join now to see all
Publications & Presentations
PubMed
- 733 citationsBRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanomaDennie T. Frederick, Adriano Piris, Alexandria P. Cogdill, Zachary A. Cooper, Cecilia Lezcano
Clinical Cancer Research. 2013-03-01 - 735 citationsEGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenibRyan B. Corcoran, Hiromichi Ebi, Alexa B. Turke, Erin M. Coffee, Michiya Nishino
Cancer Discovery. 2012-03-01 - 66 citationsClinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma.Gabriel J. Starrett, Manisha Thakuria, Tianqi Chen, Christina Marcelus, Jingwei Cheng
Genome Medicine. 2020-03-18
Press Mentions
- Large-Scale Screen of Drug Combinations Identifies Potential Treatment for Resistant, BRAF-Mutant MelanomaOctober 26th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: